Abstract:The competency of any intelligent agent is bounded by its formal account of the world in which it operates. Clinical AI lacks such an account. Existing frameworks address evaluation, regulation, or system design in isolation, without a shared model of the clinical world to connect them. We introduce the Clinical World Model, a framework that formalizes care as a tripartite interaction among Patient, Provider, and Ecosystem. To formalize how any agent, whether human or artificial, transforms information into clinical action, we develop parallel decision-making architectures for providers, patients, and AI agents, grounded in validated principles of clinical cognition. The Clinical AI Skill-Mix operationalizes competency through eight dimensions. Five define the clinical competency space (condition, phase, care setting, provider role, and task) and three specify how AI engages human reasoning (assigned authority, agent facing, and anchoring layer). The combinatorial product of these dimensions yields a space of billions of distinct competency coordinates. A central structural implication is that validation within one coordinate provides minimal evidence for performance in another, rendering the competency space irreducible. The framework supplies a common grammar through which clinical AI can be specified, evaluated, and bounded across stakeholders. By making this structure explicit, the Clinical World Model reframes the field's central question from whether AI works to in which competency coordinates reliability has been demonstrated, and for whom.
Abstract:Existing medical imaging datasets for abdominal CT often lack three-dimensional annotations, multi-organ coverage, or precise lesion-to-organ associations, hindering robust representation learning and clinical applications. To address this gap, we introduce 3DLAND, a large-scale benchmark dataset comprising over 6,000 contrast-enhanced CT volumes with over 20,000 high-fidelity 3D lesion annotations linked to seven abdominal organs: liver, kidneys, pancreas, spleen, stomach, and gallbladder. Our streamlined three-phase pipeline integrates automated spatial reasoning, prompt-optimized 2D segmentation, and memory-guided 3D propagation, validated by expert radiologists with surface dice scores exceeding 0.75. By providing diverse lesion types and patient demographics, 3DLAND enables scalable evaluation of anomaly detection, localization, and cross-organ transfer learning for medical AI. Our dataset establishes a new benchmark for evaluating organ-aware 3D segmentation models, paving the way for advancements in healthcare-oriented AI. To facilitate reproducibility and further research, the 3DLAND dataset and implementation code are publicly available at https://mehrn79.github.io/3DLAND.
Abstract:This study investigates uncertainty quantification in large language models (LLMs) for medical applications, emphasizing both technical innovations and philosophical implications. As LLMs become integral to clinical decision-making, accurately communicating uncertainty is crucial for ensuring reliable, safe, and ethical AI-assisted healthcare. Our research frames uncertainty not as a barrier but as an essential part of knowledge that invites a dynamic and reflective approach to AI design. By integrating advanced probabilistic methods such as Bayesian inference, deep ensembles, and Monte Carlo dropout with linguistic analysis that computes predictive and semantic entropy, we propose a comprehensive framework that manages both epistemic and aleatoric uncertainties. The framework incorporates surrogate modeling to address limitations of proprietary APIs, multi-source data integration for better context, and dynamic calibration via continual and meta-learning. Explainability is embedded through uncertainty maps and confidence metrics to support user trust and clinical interpretability. Our approach supports transparent and ethical decision-making aligned with Responsible and Reflective AI principles. Philosophically, we advocate accepting controlled ambiguity instead of striving for absolute predictability, recognizing the inherent provisionality of medical knowledge.
Abstract:Introduction: This study provides a comprehensive performance assessment of vision-language models (VLMs) against established convolutional neural networks (CNNs) and classic machine learning models (CMLs) for computer-aided detection (CADe) and computer-aided diagnosis (CADx) of colonoscopy polyp images. Method: We analyzed 2,258 colonoscopy images with corresponding pathology reports from 428 patients. We preprocessed all images using standardized techniques (resizing, normalization, and augmentation) and implemented a rigorous comparative framework evaluating 11 distinct models: ResNet50, 4 CMLs (random forest, support vector machine, logistic regression, decision tree), two specialized contrastive vision language encoders (CLIP, BiomedCLIP), and three general-purpose VLMs ( GPT-4 Gemini-1.5-Pro, Claude-3-Opus). Our performance assessment focused on two clinical tasks: polyp detection (CADe) and classification (CADx). Result: In polyp detection, ResNet50 achieved the best performance (F1: 91.35%, AUROC: 0.98), followed by BiomedCLIP (F1: 88.68%, AUROC: [AS1] ). GPT-4 demonstrated comparable effectiveness to traditional machine learning approaches (F1: 81.02%, AUROC: [AS2] ), outperforming other general-purpose VLMs. For polyp classification, performance rankings remained consistent but with lower overall metrics. ResNet50 maintained the highest efficacy (weighted F1: 74.94%), while GPT-4 demonstrated moderate capability (weighted F1: 41.18%), significantly exceeding other VLMs (Claude-3-Opus weighted F1: 25.54%, Gemini 1.5 Pro weighted F1: 6.17%). Conclusion: CNNs remain superior for both CADx and CADe tasks. However, VLMs like BioMedCLIP and GPT-4 may be useful for polyp detection tasks where training CNNs is not feasible.
Abstract:This study evaluated self-reported response certainty across several large language models (GPT, Claude, Llama, Phi, Mistral, Gemini, Gemma, and Qwen) using 300 gastroenterology board-style questions. The highest-performing models (GPT-o1 preview, GPT-4o, and Claude-3.5-Sonnet) achieved Brier scores of 0.15-0.2 and AUROC of 0.6. Although newer models demonstrated improved performance, all exhibited a consistent tendency towards overconfidence. Uncertainty estimation presents a significant challenge to the safe use of LLMs in healthcare. Keywords: Large Language Models; Confidence Elicitation; Artificial Intelligence; Gastroenterology; Uncertainty Quantification




Abstract:Background: This study aimed to evaluate and compare the performance of classical machine learning models (CMLs) and large language models (LLMs) in predicting mortality associated with COVID-19 by utilizing a high-dimensional tabular dataset. Materials and Methods: We analyzed data from 9,134 COVID-19 patients collected across four hospitals. Seven CML models, including XGBoost and random forest (RF), were trained and evaluated. The structured data was converted into text for zero-shot classification by eight LLMs, including GPT-4 and Mistral-7b. Additionally, Mistral-7b was fine-tuned using the QLoRA approach to enhance its predictive capabilities. Results: Among the CML models, XGBoost and RF achieved the highest accuracy, with F1 scores of 0.87 for internal validation and 0.83 for external validation. In the LLM category, GPT-4 was the top performer with an F1 score of 0.43. Fine-tuning Mistral-7b significantly improved its recall from 1% to 79%, resulting in an F1 score of 0.74, which was stable during external validation. Conclusion: While LLMs show moderate performance in zero-shot classification, fine-tuning can significantly enhance their effectiveness, potentially aligning them closer to CML models. However, CMLs still outperform LLMs in high-dimensional tabular data tasks.